150 related articles for article (PubMed ID: 23715500)
1. A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression.
Cheng M; Yang L; Yang R; Yang X; Deng J; Yu B; Huang D; Zhang S; Wang H; Qiu F; Zhou Y; Lu J
Carcinogenesis; 2013 Oct; 34(10):2292-9. PubMed ID: 23715500
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer.
Wang Q; Liu H; Xiong H; Liu Z; Wang LE; Qian J; Muddasani R; Lu V; Tan D; Ajani JA; Wei Q
Mol Carcinog; 2015 Jun; 54(6):449-58. PubMed ID: 24302553
[TBL] [Abstract][Full Text] [Related]
3. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.
Wang X; Hu JF; Tan Y; Cui J; Wang G; Mrsny RJ; Li W
PLoS One; 2014; 9(5):e95915. PubMed ID: 24787949
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the stem cell marker gene
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the Stem Cell Marker Gene CD133 and the Risk of Lung Cancer in Chinese Population.
Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
Lung; 2016 Jun; 194(3):393-400. PubMed ID: 27130457
[TBL] [Abstract][Full Text] [Related]
7. A functional polymorphism at microRNA-629-binding site in the 3'-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese population.
Yang L; Li Y; Cheng M; Huang D; Zheng J; Liu B; Ling X; Li Q; Zhang X; Ji W; Zhou Y; Lu J
Carcinogenesis; 2012 Feb; 33(2):338-47. PubMed ID: 22114071
[TBL] [Abstract][Full Text] [Related]
8. Is CD133 expression a prognostic biomarker of non-small-cell lung cancer? A systematic review and meta-analysis.
Wu H; Qi XW; Yan GN; Zhang QB; Xu C; Bian XW
PLoS One; 2014; 9(6):e100168. PubMed ID: 24940615
[TBL] [Abstract][Full Text] [Related]
9. Influences of two significant variants located in the ST6GAL1 3'-untranslated region on lung carcinoma susceptibility in the Chinese Han population.
Liu X; Chen L; Ren Z; Tian X
Eur J Cancer Prev; 2020 Jan; 29(1):60-64. PubMed ID: 31794515
[TBL] [Abstract][Full Text] [Related]
10. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
Wu B; Sun C; Feng F; Ge M; Xia L
J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
[TBL] [Abstract][Full Text] [Related]
11. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD133 antigen in cancer.
Ferrandina G; Petrillo M; Bonanno G; Scambia G
Expert Opin Ther Targets; 2009 Jul; 13(7):823-37. PubMed ID: 19530986
[TBL] [Abstract][Full Text] [Related]
13. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells.
Shen WW; Zeng Z; Zhu WX; Fu GH
J Mol Med (Berl); 2013 Aug; 91(8):989-1000. PubMed ID: 23619912
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
[TBL] [Abstract][Full Text] [Related]
15. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.
Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A
J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669
[TBL] [Abstract][Full Text] [Related]
16. MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females.
Yin Z; Cui Z; Ren Y; Xia L; Li H; Zhou B
Oncotarget; 2017 Jan; 8(2):2275-2283. PubMed ID: 27911870
[TBL] [Abstract][Full Text] [Related]
17. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
18. Sequence Variation in Mature MicroRNA-499 Confers Unfavorable Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy.
Qiu F; Yang L; Ling X; Yang R; Yang X; Zhang L; Fang W; Xie C; Huang D; Zhou Y; Lu J
Clin Cancer Res; 2015 Apr; 21(7):1602-13. PubMed ID: 25614447
[TBL] [Abstract][Full Text] [Related]
19. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
[TBL] [Abstract][Full Text] [Related]
20. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
